Therapeutic Challenges to End-Stage Kidney Disease in a Patient with Tetralogy of Fallot
Ken Ohara(Jichi Medical University), Daisuke Nagata(Jichi Medical University), Takahiro Masuda(Jichi Medical University), Tetsu Akimoto(Jichi Medical University), Shin’ichi Takeda(Kushiro City General Hospital), Taro Sugase(Jichi Medical University), Naoko Otani(Jichi Medical University), Shigeaki Muto(Jichi Medical University), Toshimi Imai(Jichi Medical University), Takuya Murakami(Jichi Medical University), Takuya Miki(Jichi Medical University)
Cited by 9
Related Papers
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
|American Journal of Physiology-Renal Physiology|2013|481
AMP-activated Protein Kinase (AMPK) Signaling in Endothelial Cells Is Essential for Angiogenesis in Response to Hypoxic Stress
|Journal of Biological Chemistry|2003|328
Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia
|American Journal of Physiology-Renal Physiology|2013|308
Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice
|American Journal of Physiology-Renal Physiology|2012|158
Osmotic diuresis by SGLT2 inhibition stimulates vasopressin‐induced water reabsorption to maintain body fluid volume
|Physiological Reports|2020|135